Rationale and Design of the EMPERIAL-Preserved and EMPERIAL-Reduced Trials of Empagliflozin in Patients With Chronic Heart Failure
European Journal of Heart Failure - United States
doi 10.1002/ejhf.1486
Full Text
Open PDFAbstract
Available in full text
Date
June 19, 2019
Authors
Publisher
Wiley